50474-710Level 3
Cimzia (certolizumab pegol)
**Product type:** Human Prescription Drug
**Active ingredient:** CERTOLIZUMAB PEGOL
**Strength:** 200 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** UCB, Inc.
**Marketing category:** BLA (BLA125160)
**Pharmacologic class:** Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
GET
/api/v1/systems/ndc_fda/nodes/50474-710Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.